Cobblestone Capital Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.8M | Sell |
24,765
-58
| -0.2% | -$35.2K | 0.76% | 34 |
|
|
2025
Q2 | $13.3M | Buy |
24,823
+235
| +1% | +$112K | 0.68% | 35 |
|
|
2025
Q1 | $10.3M | Buy |
24,588
+92
| +0.4% | +$39.9K | 0.57% | 41 |
|
|
2024
Q4 | $10.1M | Buy |
24,496
+12
| +0% | +$5.26K | 0.55% | 42 |
|
|
2024
Q3 | $12.4M | Buy |
24,484
+244
| +1% | +$119K | 0.69% | 39 |
|
|
2024
Q2 | $11.8M | Sell |
24,240
-200
| -0.8% | -$100K | 0.73% | 38 |
|
|
2024
Q1 | $13.2M | Sell |
24,440
-8
| -0% | -$4.37K | 0.83% | 35 |
|
|
2023
Q4 | $13.6M | Sell |
24,448
-338
| -1% | -$159K | 0.89% | 35 |
|
|
2023
Q3 | $10.8M | Sell |
24,786
-311
| -1% | -$155K | 0.8% | 37 |
|
|
2023
Q2 | $12.6M | Sell |
25,097
-287
| -1% | -$138K | 0.89% | 33 |
|
|
2023
Q1 | $12.7M | Sell |
25,384
-473
| -2% | -$226K | 0.95% | 32 |
|
|
2022
Q4 | $10.5M | Sell |
25,857
-305
| -1% | -$118K | 0.81% | 37 |
|
|
2022
Q3 | $8.52M | Sell |
26,162
-451
| -2% | -$166K | 0.71% | 37 |
|
|
2022
Q2 | $9.33M | Sell |
26,613
-181
| -0.7% | -$73.8K | 0.71% | 37 |
|
|
2022
Q1 | $14.7M | Sell |
26,794
-325
| -1% | -$171K | 0.99% | 31 |
|
|
2021
Q4 | $17.9M | Buy |
27,119
+343
| +1% | +$215K | 1.15% | 31 |
|
|
2021
Q3 | $16.7M | Sell |
26,776
-218
| -0.8% | -$146K | 1.14% | 30 |
|
|
2021
Q2 | $17M | Sell |
26,994
-5,137
| -16% | -$2.84M | 1.15% | 29 |
|
|
2021
Q1 | $15.7M | Sell |
32,131
-383
| -1% | -$192K | 1.14% | 30 |
|
|
2020
Q4 | $16.3M | Sell |
32,514
-1,320
| -4% | -$591K | 1.25% | 28 |
|
|
2020
Q3 | $13.3M | Sell |
33,834
-8,525
| -20% | -$3.15M | 1.15% | 30 |
|
|
2020
Q2 | $14M | Buy |
42,359
+2,582
| +6% | +$748K | 1.26% | 28 |
|
|
2020
Q1 | $9.64M | Buy |
39,777
+446
| +1% | +$116K | 1.04% | 31 |
|
|
2019
Q4 | $10.3M | Sell |
39,331
-216
| -0.5% | -$56.9K | 0.93% | 33 |
|
|
2019
Q3 | $10.8M | Sell |
39,547
-890
| -2% | -$248K | 1.07% | 28 |
|
|
2019
Q2 | $11.1M | Sell |
40,437
-240
| -0.6% | -$59.1K | 1% | 30 |
|
|
2019
Q1 | $9.1M | Sell |
40,677
-890
| -2% | -$184K | 0.85% | 35 |
|
|
2018
Q4 | $7.73M | Sell |
41,567
-7,840
| -16% | -$1.61M | 0.8% | 38 |
|
|
2018
Q3 | $12.3M | Sell |
49,407
-854
| -2% | -$207K | 1.16% | 23 |
|
|
2018
Q2 | $11M | Sell |
50,261
-712
| -1% | -$147K | 1.08% | 23 |
|
|
2018
Q1 | $9.76M | Sell |
50,973
-790
| -2% | -$146K | 0.99% | 29 |
|
|
2017
Q4 | $8.1M | Buy |
51,763
+198
| +0.4% | +$31.2K | 0.8% | 36 |
|
|
2017
Q3 | $8.02M | Buy |
51,565
+225
| +0.4% | +$35.6K | 0.99% | 31 |
|
|
2017
Q2 | $8.29M | Sell |
51,340
-965
| -2% | -$157K | 1.08% | 25 |
|
|
2017
Q1 | $8.09M | Sell |
52,305
-264
| -0.5% | -$36.4K | 1.08% | 24 |
|
|
2016
Q4 | $6.17M | Sell |
52,569
-475
| -0.9% | -$54.2K | 0.85% | 36 |
|
|
2016
Q3 | $5.98M | Sell |
53,044
-2,915
| -5% | -$307K | 0.85% | 32 |
|
|
2016
Q2 | $5.2M | Sell |
55,959
-165
| -0.3% | -$14.2K | 0.74% | 44 |
|
|
2016
Q1 | $4.4M | Buy |
56,124
+1,880
| +3% | +$135K | 0.64% | 46 |
|
|
2015
Q4 | $3.96M | Buy |
54,244
+1,385
| +3% | +$98.8K | 0.59% | 48 |
|
|
2015
Q3 | $3.92M | Buy |
+52,859
| New | +$3.79M | 0.63% | 45 |
|
Other funds holding IDXX
Cobblestone Capital Advisors's IDXX Position: Q3 2025 in Review
Cobblestone Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 0.23% in Q3 2025, selling an estimated $35.2K and leaving 24,765 shares worth $15.8M. The position accounts for 0.76% of the portfolio, ranked #34.
Cobblestone Capital Advisors first reported a position in IDXX in Q3 2015 and has held it in 41 quarters since. The position peaked at $17.9M in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.
- Cobblestone Capital Advisors held 24,765 shares of Idexx Laboratories worth $15.8M as of Q3 2025.
- Cobblestone Capital Advisors sold 58 Idexx Laboratories shares in Q3 2025, an estimated $35.2K.
- Idexx Laboratories made up 0.76% of Cobblestone Capital Advisors's portfolio in Q3 2025, its #34 holding.
- Cobblestone Capital Advisors first reported a position in Idexx Laboratories in Q3 2015 and has held it in 41 quarters since.
- Cobblestone Capital Advisors's Idexx Laboratories position peaked at $17.9M in Q4 2021.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.
Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.